Skip to main content
OpenTrials

Clinical trial condition

Post-essential Thrombocythemia Myelofibrosis

Explore clinical trials studying Post-essential Thrombocythemia Myelofibrosis. Study availability and eligibility vary by location and protocol.

27 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Post-essential Thrombocythemia Myelofibrosis trial results

Completed

A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Participants (MOMENTUM)

NCT04173494

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +5 more
Locations
  • Mayo Clinic Hospital - Phoenix Phoenix, Arizona, United States
  • Irvine Center for Clinical Research Irvine, California, United States
  • Norris Comprehensive Cancer Center Los Angeles, California, United States
  • American Institute of Research - Whittier Whittier, California, United States
View all 167 locations
View Trial Details
Completed

Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia

NCT02124746

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • Scottsdale, Arizona, United States
  • Orange, California, United States
  • Stanford, California, United States
  • Whittier, California, United States
View all 22 locations
View Trial Details
Completed

Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF

NCT01423851

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +14 more
Locations
  • Mayo Clinic Scottsdale Recruiting Scottsdale, Arizona, United States
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • Mayo Clinic, Jacksonville Jacksonville, Florida, United States
  • Northwestern University Chicago, Illinois, United States
View Trial Details
Completed

A Phase 2 Study of RO7490677 In Participants With Myelofibrosis

NCT01981850

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Fibrosis, +11 more
Locations
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Emory Hospital Atlanta, Georgia, United States
  • University of Maryland Medical Center Baltimore, Maryland, United States
View all 23 locations
View Trial Details
Completed

PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

NCT03065400

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Chronic Phase Myelofibrosis, +9 more
Locations
  • Harvard Medical School Massachusetts General Hospital Boston, Massachusetts, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Montefiore Medical Center Division of Hematology, Department of Oncology The Bronx, New York, United States
View Trial Details

Related conditions